The VIVA Foundation

11/10/2025

One week ago, STORM-PE data made waves when presented live at hashtag and published in Circulation.

Dr. Rachel Rosovsky stopped by to discuss the impact of the findings and how they may shape future treatment strategies.

Tap to watch her quick recap:

11/05/2025

11/05/2025

Cheers to our top scorers in the
Face-Off Competition!

Congratulations to all on your outstanding presentations and contributions to the field!

11/05/2025

Grateful to share the stage and fellowship with esteemed multidisciplinary clinicians from around the world—all united by one purpose: to preserve the dignity of those we serve.

From the live cases at University Hospital Leipzig to panels on saving limbs and lives, and improving vascular care for the disadvantaged, the conversations were powerful reminders that excellence in medicine isn’t just about technical mastery—it’s about compassion, collaboration, and commitment.

Bravo to the VIVA team for another world-class meeting that pushes the boundaries of what’s possible in vascular innovation and human connection. Together, we’re redefining hope for patients who have too often been forgotten. The VIVA Foundation

11/05/2025

Dr. Jay Giri breaks down real-world data comparing outcomes in pulmonary embolism patients treated with large-bore mechanical thrombectomy vs. anticoagulation alone. Catch his key takeaways from Sunday’s presentation.

11/05/2025

Day 2 ends with the release of our fourth and final round of Late-Breaking Clinical Trials at . Another incredible day of data, dialogue, and discovery shaping what’s next in vascular medicine.

Read the release: https://viva-foundation.org/news-article?id=211165

11/04/2025

Hands-on learning in action. At ’s Cadaver Lab, participants are refining techniques, testing devices, and bringing real-world application to vascular innovation.

11/04/2025

Third round of Late-Breaking Clinical Trial data is now available. Read the release here:

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, today announced results from the third round of Late-Breaking Clinical Trials presented at VIVA 2025, held at Wynn Las Vegas.

11/04/2025

Late-breaking data spotlight!

After presenting late-breaking data from the JURY-2 Study at on Sunday, Dr. Yana Etkin gave us a quick recap on the trial’s purpose and impact.

11/04/2025

Wrapping up day 1! The second round of Late-Breaking Clinical Trial data summaries is available on our website now:

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, today announced results from the second round of Late-Breaking Clinical Trials presented at VIVA 2025, held at Wynn Las Vegas.

11/03/2025

The Physicians-in-Training Program continues today at with the highly anticipated Face-Off Competition. Following last night’s reception, participants are showcasing innovative research and clinical insights—representing the next generation of vascular excellence.

11/03/2025

⭐️Breaking news from : STORM-PE trial data presented today simultaneously published in Circulation.

We’re excited to see these groundbreaking findings recognized in one of the field’s leading journals.

Read the publication:

Background: Patients with intermediate-high risk pulmonary embolism (PE) have an elevated right-to-left-ventricular (RV/LV) diameter ratio and are at risk of early clinical decompensation and mortality. Reperfusion therapy aims to rapidly relieve acute RV pressure overload and normalize hemodynamics...